Detecting respiratory syncytial virus using nanoparticle-amplified immuno-PCR

Methods in Molecular Biology

Volumn 1026, Issue , 2013, Pages 93-110

  Perez, Jonas W ^a   Adams, Nicholas M ^a   Zimmerman, Grant R ^a   Haselton, Frederick R ^a   Wright, David W ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Gold nanoparticle; Immuno PCR; Magnetic extraction; PCR; Respiratory syncytial virus; Viral detection

Indexed keywords

DNA; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOPARTICLE; PALIVIZUMAB; QUANTUM DOT; SURFACE FUSION PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; CELL LYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEATING; IMMUNO POLYMERASE CHAIN REACTION; LIMIT OF DETECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84883175423     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-468-5_8     Document Type: Article

References (23)

1. Robert CW (2003) Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 143:112-117
2. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ (1999) Bronchiolitisassociated hospitalizations among US children, 1980-1996. J Am Med Assoc 282:1440-1446
3. Falsey AR, Walsh EE (2005) Respiratory syncytial virus infection in elderly adults. Drugs Aging 22:577-587
4. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352:1749-1759
5. Hall CB (2001) Respiratory syncytial virus and parain fluenza virus. N Engl J Med 344:1917-1928
6. Moore E, Barber J, Tripp R (2008) Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15). Virol J 5:116
7. Tripp RA (2004) Pathogenesis of respiratory syncytial virus infection. Viral Immunol 17:165-181
8. Chin J, Magof fin RL, Shearer LA, Schieble JH, Lennette EH (1969) Field evaluation of a respiratory syncytial virus vaccine and a trivalent parain fluenza virus vaccine in a pediatric population. Am J Epidemiol 89:449-463
9. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE (1969) An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405-421
10. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89:422-434
11. Kaur J, Tang RS, Spaete RR, Schickli JH (2008) Optimization of plasmid-only rescue of highly attenuated and temperature-sensitive respiratory syncytial virus (RSV) vaccine candidates for human trials. J Virol Methods 153:196-202
12. Committee on Infectious Diseases, Committee on Fetus and Newborn (1998) Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 102:1211-1216
13. Meissner HC, Bocchini JA Jr, Brady MT, Hall CB, Kimberlin DW, Pickering LK (2009) The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus. Pediatrics 124:1676-1679
14. Committee on Infectious Diseases (1996) Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 97:137-140
15. Goodrich JS, Miller MB (2007) Comparison of Cepheid's analyte-speci fic reagents with BD directigen for detection of respiratory syncytial virus. J Clin Microbiol 45:604-606
16. Perkins SM, Webb DL, Torrance SA, El Saleeby C, Harrison LM, Aitken JA, Patel A, DeVincenzo JP (2005) Comparison of a realtime reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus. J Clin Microbiol 43:2356-2362
17. Chomczynski P (1992) Solubilization in formamide protects RNA from degradation. Nucleic Acids Res 20:3791-3792
18. Hargrove JL, Schmidt FH (1989) The role of mRNA and protein stability in gene expression. FASEB J 3:2360-2370
19. Mahony JB (2008) Detection of respiratory viruses by molecular methods. Clin Microbiol Rev 21:716-747
20. Bentzen EL, House F, Utley TJ, Crowe JE, Wright DW (2005) Progression of respiratory syncytial virus infection monitored by fluorescent quantum dot probes. Nano Lett 5:591-595
21. Adler M, Schulz S, Fischer R, Niemeyer CM (2005) Detection of Rotavirus from stool samples using a standardized immuno-PCR ("Imperacer") method with end-point and real-time detection. Biochem Biophys Res Commun 333:1289-1294
22. Barletta J, Bartolome A (2007) Immunopolymerase chain reaction as a unique molecular tool for detection of infectious agents. Expert Opin Med Diagn 1:267-288
23. Stowers CC, Haselton FR, Boczko EM (2010) An analysis of quantitative PCR reliability through replicates using the Ct method. J Biomed Sci Eng 3:459-469